Massachusetts Veterinary Referral Hospital
Specialty hospital / research center
2 current cancer treatment or research opportunities
About Massachusetts Veterinary Referral Hospital
Massachusetts Veterinary Referral Hospital is the participating hospital named in the current study listing below. The hospital is part of the Ethos Veterinary Health network, while Ethos Discovery coordinates the research program. Screening, enrollment and required visits are handled by the participating hospital; owners should confirm that the location is still enrolling before making travel plans.
Massachusetts Veterinary Referral Hospital official website →
Who the current listings are forDogs
Cancer types currently listedHemangiosarcoma, Osteosarcoma
Where visits take placeMassachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
Current options at Massachusetts Veterinary Referral Hospital
Open an option to see who may qualify, locations, costs or coverage, contact details and the official source.
Novel vaccine versus carboplatin after amputation for canine appendicular osteosarcoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Appendicular OSA; age >=1 year, >=44 lb, otherwise in good general health; cytologic/histologic confirmation. Current Ethos owner page lists 9 enrolling hospitals. An older AVMA registry listing contains additional historical sites; those are not promoted without current site-level confirmation.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 44; Active tumor required; Appendicular location; Min age years: 1; Planned amputation
Costs / coverage: 🟡 Partially funded. All study-related visits are covered, including up to $4,000 toward amputation.
Contact: Contact participating Ethos hospital through official study page.
Location
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
Official study / enrollment information →
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Location
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
Official study / enrollment information →
Before you contact the center
A listing here does not mean every pet will qualify. Enrollment can change, and the study team makes the final decision after reviewing your pet’s diagnosis, records and previous treatment.
Have the pathology report, recent imaging and treatment history ready. Ask whether a referral is required, which visits must happen in person and what the study pays for before making travel plans.
Check all options for your pet →
Free to use. No registration or paid report.
